Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
The 10 most talked-about journal articles about Alzheimer’s Disease
Posted on August 2nd, 2016 by Betsy Davis in Pharma R&D
The Alzheimer’s Association International Conference just wrapped up in Toronto, Canada (Patrick May was there and will be writing all about it). In honor of the conference, here is a list of Alzheimer’s-related journal articles that were most-talked about in the last month in social media, blogs, and news coverage.
- An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition
- Tau immunotherapy for Alzheimer’s disease
- Ketones block amyloid entry and improve cognition in an Alzheimer’s model
- Cognitive deficits in single App knock-in mouse models
- 2016 Alzheimer’s disease facts and figures
- Mice are not Men: ADAM30 Findings Emphasize a Broader Look Towards Murine Alzheimer’s Disease Models
- The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer’s disease
- ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer’s Disease
- The blood-brain barrier in Alzheimer’s disease
- Sorting Out Presenilins in Alzheimer’s Disease
Discover all these articles and more on ScienceDirect.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Senior Strategic Marketing Manager
- Re-Inventing R&D for Precision Medicine
- Predicting Adverse Event Risks and Gaining Insights from Disparate Data
- Avoiding the Risks of Being Wrong in Drug Discovery
- How Are You Handling Big Data & Innovation?
- Making Precision Medicine a Reality